Purposeful Drug Repurposing
This Viewpoint discusses a proposal to identify candidates for drug repurposing and allocate US Food and Drug Administration funds to cover the cost of evaluating and approving such drugs for their novel indications.
Authors
- Peter Nägele (ORCID: https://orcid.org/0000-0001-8369-3858)
- Charles R. Conway (ORCID: https://orcid.org/0000-0001-6849-9416)
- Charles F. Zorumski (ORCID: https://orcid.org/0000-0002-9704-5154)
Institutions
- Washington University in St. Louis (US)
- University of Chicago (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1001/jamapsychiatry.2025.0900
- Citations
- 2
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 2.79